CD4 and neoplasm: In a murine pancreatic ductal adenocarcinoma model, a single UTMC treatment increased tumoral cytoplasmic HMGB1 and enhanced antigen presentation by macrophages, CTLs, and CD4+ cells only in TDLNs at 2 days after UTMC, which resulted in reduced tumor growth [160].